Claudia Lombardo

Suggest Changes
Learn More
PURPOSE The progressive immune dysfunctions that occur in patients with advanced melanoma make them unlikely to efficiently respond to cancer vaccines. A multicenter randomized phase II trial was(More)
  • 1